• Vaccine Name: Tetanus Toxoid Adsorbed by Sanofi Pasteur Inc
• Target Pathogen: Clostridium tetani
• Target Disease: Tetanus
• Product Name: Tetanus Toxoid Adsorbed
• Tradename: None
• Manufacturer: Sanofi Pasteur, Inc.
• Vaccine Ontology ID: VO_0000033
• CDC CVX code: 28
• Type: Toxoid vaccine
• Status: Licensed
• Location Licensed: USA (License #1725)
• Adjuvant:
  • Adjuvant name:
  • VO adjuvant ID: VO_0000128
• Preparation: C. tetani culture is grown in a peptone-based medium containing an extract of bovine muscle tissue and detoxified with formaldehyde. The detoxified material is purified by serial ammonium sulfate fractionation and diafiltration, followed by sterile filtration. The toxoid is adsorbed to aluminum potassium sulfate (alum). The adsorbed toxoid is diluted with physiological saline solution (0.85%) (FDA: Tetanus Toxoid Adsorbed by Sanofi Pasteur Inc).
• Immunization Route: Intramuscular injection (i.m.)
• Storage: Store between 2° – 8°C (35° – 46°F). DO NOT FREEZE.
• Contraindication: This vaccine should not be administered to anyone with a known hypersensitivity to any component of the vaccine, including thimerosal (FDA: Tetanus Toxoid Adsorbed by Sanofi Pasteur Inc)
• Description: Tetanus Toxoid Adsorbed manufactured by Aventis Pasteur Inc., for intramuscular injection, is a sterile suspension of alum-precipitated (aluminum potassium sulfate) toxoid in an isotonic sodium chloride solution (FDA: Tetanus Toxoid Adsorbed).

Human Response

• Side Effects: Side effects of vaccination are: injection site reactions, fever, and nausea.